Breakout I. Ethical considerations.

R J McKenna; J Laszlo; J Durant; J F Hermann; C Huguley; B Leventhal; E Roach; M Siegler

doi:10.1002/1097-0142(19900515)65:10+<2407::aid-cncr2820651513>3.0.co;2-d

PubMed · 2185876

Breakout I. Ethical considerations.

R J McKenna·J Laszlo·J Durant·J F Hermann·C Huguley·B Leventhal·E Roach·M Siegler

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

American Cancer Society Attitude of Health Personnel Clinical Trials as Topic Costs and Cost Analysis Ethics, Medical Health Services Accessibility Humans Informed Consent Neoplasms Patient Advocacy Quality of Life Randomized Controlled Trials as Topic United States Clinical Trial Journal Article Randomized Controlled Trial

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R J McKenna, J Laszlo, J Durant, J F Hermann, C Huguley, B Leventhal, E Roach, M Siegler. 1990-05-15. Breakout I. Ethical considerations.. https://doi.org/10.1002/1097-0142(19900515)65%3A10%2B%3C2407%3A%3Aaid-cncr2820651513%3E3.0.co%3B2-d

Cite the original work for its findings. Save a collection to share your selection of sources.

Breakout I. Ethical considerations.

Abstract

Explore related subjects

Keep this discovery

Related citations

Control plans help states fight cancer locally.

Senate health plan legislation opposed by ACS.

State by state comparison of insurance regulations.